Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Submit Your Information
Create a Profile
Get In Touch Mobile
Olga Novikov-King
Olga Novikov-King
Dr. Olga Novikov-King is a board-certified psychiatrist with an MD-PhD from Boston University School of Medicine and a strong background in translational research and clinical care. She currently serves as an Investigator at Accel Research Sites in St. Petersburg–Largo, FL, while maintaining active clinical practice in both in-person and telepsychiatry settings. Dr. Novikov-King has experience managing diverse psychiatric populations across inpatient and outpatient environments, supporting robust patient recruitment and retention. She is licensed in Massachusetts and Florida, GCP certified, and holds a PCCS-MAT Buprenorphine Waiver, enabling engagement with substance use disorder populations. Her research experience includes multiple peer-reviewed publications and academic presentations, reflecting a solid foundation in clinical and scientific rigor. Dr. Novikov-King is well-positioned to successfully execute CNS clinical trials with high-quality oversight and patient-centered care.
Articles
Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Jim Leary Joins Alcanza as Chief Information Officer
Alcanza Clinical Research Announces Launch of Enspire Clinical Research in Illinois
Ready to be part of healthcare history? Find the right clinical trial for you.
